Now available VYJUVEK™

VYJUVEK™ (beremagene geperpavec-svdt) biological suspension mixed with excipient gel for topical application is a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy indicated for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.